
Holding the Line in AML: Real-World Care Meets Breakthrough Trials
The HemOnc Pulse
00:00
NPM1 biology and risk profile
Eunice Wang explains NPM1's favorable classification, its limits, and relapse risks in AML.
Play episode from 00:43
Transcript


